CCA
ZYME icon

Cygnus Capital Advisors’s Zymeworks ZYME Stock Holding History

Cygnus Capital Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,197
Closed -$205K – 109
2026
Q1 		$205K Buy
8,197
+2,200
+37% +$52.1K 0.14% 52
2025
Q4 		$158K Buy
+5,997
New +$131K 0.12% 53

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Cygnus Capital Advisors's ZYME Position: Q2 2026 in Review

Cygnus Capital Advisors sold out of Zymeworks (ZYME) in Q2 2026, closing a stake of 8,197 shares — an estimated $205K sold.

Cygnus Capital Advisors first reported a position in ZYME in Q4 2025 and held it in 2 quarters. The position peaked at $205K in Q1 2026. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Cygnus Capital Advisors reported no remaining Zymeworks position as of Q2 2026 after selling out during the quarter.
  • Cygnus Capital Advisors sold 8,197 Zymeworks shares in Q2 2026, an estimated $205K.
  • Cygnus Capital Advisors first reported a position in Zymeworks in Q4 2025 and held it in 2 quarters.
  • Cygnus Capital Advisors's Zymeworks position peaked at $205K in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Cygnus Capital Advisors's 13F filing for Q2 2026, filed 3 Sep 2026.